Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:629 (22 March), doi:10.1136/bmj.39520.507025.3A
| The first 150 words of the full text of this article appear below. |
I would like to add to Lenzer and Brownlees reporting of my comments on how excessively closed science can hurt physicians and patients.1
Statistician Michael Bracken led the NASCIS 2 and 3 studies of high dose steroids in acute spinal cord injury.2 The National Institute of Neurological Disorders and Stroke conducted a public campaign in advance of the scientific publication of NASCIS 2 on 17 May 1990. The institute sent a fax on 13 April 1990 to some 19 000 emergency room physicians and hospitals, after a press release had resulted in coverage by the New York Times and the Chicago Tribune on 31 March 1990, by Science News on 7 April 1990, by Newsweek on 9 April 1990.
This led to widespread use of steroids, off label. No application for regulatory approval for this indication was completed, and no agency ever approved it. Surgeons report that methylprednisolone is administered
Fred H. Geisler, director
1 Illinois Neuro-Spine Center, 2020 Ogden Ave, Suite 335, Aurora, IL 60504
fgeisler@gmail.com